MedTech News
.................... by Andrew Celentano
New liquid biopsy technology can detect disease from a drop of blood
An innovative platform developed by PKU researchers called “cf-EpiTracing” has proved capable of detecting and tracing diseases from as little as 50 μl of human plasma, or roughly a drop of blood. The research, published in Nature on March 4, 2026, was led by Professor He Aibin from the College of Future Technology and Professor Jing Hongmei from the Department of Hematology, PKU Third Hospital.
Microfluidic chip tracks cancer relapse by measuring white blood cell adhesion
A new microfluidic technology that leverages immune cell behavior is set to transform cancer monitoring, thanks to researchers at UNIST. Led by Professor Joo Hun Kang in the Department of Biomedical Engineering at UNIST, the team has introduced a novel diagnostic chip that analyzes the adhesion properties of leukocytes, or white blood cells, to detect cancer recurrence and evaluate the effectiveness of chemotherapy.
Upgraded smart mask tracks breath biomarkers for days with solar cell
“The smart mask is a low-cost way of providing continuous health care monitoring.”
New sensor sniffs out pneumonia on a patient’s breath
The technology could enable fast, point-of-care diagnoses for pneumonia and other lung conditions.
‘Bugs delivering drugs’: A new approach to colorectal cancer treatment using common food-borne bacteria
Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells.
Dark sweet cherries may help slow aggressive breast cancer, mouse study suggests
From cobblers to smoothies, dark sweet cherries show up in plenty of recipes, and scientists say the crimson-colored fruit may contain compounds that could help fight an aggressive type of breast cancer.
Neuracle reportedly wins first BCI approval in China
According to multiple reports, the Chinese medical device regulatory body granted Neuracle the country’s first approval for a brain-computer interface (BCI).
FDA-approved cancer drug fedratinib reshapes how cell organelles communicate, providing new therapeutic avenues
Cells behave like cities and organelles carry out infrastructural roles: mitochondria are powerhouses, the endoplasmic reticulum serves as a transport hub and lysosomes help with waste disposal.